Abbott Laboratories buy Royal Bank of Canada
Start price
17.04.25
/
50%
€116.00
Target price
17.04.26
€127.60
Performance (%)
-2.02%
Price
02.07.25
€113.66
Summary
This prediction is currently active. With a performance of -2.02%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 17.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -3.596% | -3.596% |
iShares Core DAX® | 1.263% | -1.123% |
iShares Nasdaq 100 | 0.531% | 2.176% |
iShares Nikkei 225® | 1.532% | 1.686% |
iShares S&P 500 | 0.904% | 1.784% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Royal Bank of Canada from $140.00 to $145.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.84
21.01.25
21.01.25
€129.42
21.01.26
21.01.26
2.54%
02.07.25
02.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.40
08.10.24
08.10.24
€118.39
08.10.25
08.10.25
9.90%
02.07.25
02.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
23.76%
05.06.25
05.06.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
13.67%
20.04.25
20.04.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
19.97%
15.02.25
15.02.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
16.23%
26.01.25
26.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
6.29%
12.01.25
12.01.25